Acutus Medical, Inc.

Equities

AFIB

US0051111096

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets Other stock markets 20:49:44 17/05/2024 BST			5-day change	1st Jan Change
0.059 ^USD	+31.11%		+43.90%	-70.78%

05-13	Acutus Medical, Inc.(NasdaqCM:AFIB) dropped from S&P TMI Index	CI
05-09	Earnings Flash (AFIB) ACUTUS MEDICAL Posts Q1 Continuing Operations Revenue $3.6M	MT

Acutus Medical, Inc. Provides Revenue Guidance for the First Quarter 2023

April 20, 2023 at 02:14 pm

Acutus Medical, Inc. provided revenue guidance for the first quarter 2023. The company expects first quarter 2023 revenue in the range of $4.1 million to $4.2 million compared to $3.7 million in the first quarter of 2022.

Latest news about Acutus Medical, Inc.

Acutus Medical, Inc.(NasdaqCM:AFIB) dropped from S&P TMI Index	05-12	CI
Earnings Flash (AFIB) ACUTUS MEDICAL Posts Q1 Continuing Operations Revenue $3.6M	05-09	MT
Acutus Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09	CI
Acutus Medical, Inc.(NasdaqCM:AFIB) dropped from NASDAQ Composite Index	05-07	CI
North American Morning Briefing : Focus Turns to -2-	04-04	DJ
Acutus Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-01	CI
BIOTRONIK SE & Co. KG Announces Termination of Bi-Lateral Distribution Agreements with Acutus Medical, Inc	02-08	CI
Wall Street Set to Open Marginally Lower Friday; December Inflation Data Lower Than Forecast	01-26	MT
Acutus Medical, Inc. Announces Board Changes	01-17	CI
Earnings Flash (AFIB) ACUTUS MEDICAL Posts Q3 Revenue $5.2M, vs. Street Est of $4.8M	11-08	MT
Acutus Medical, Inc. Announces Chief Executive Officer Changes	11-08	CI
Acutus Medical, Inc. Announces Management Resignations	11-08	CI
Acutus Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-08	CI
Transcript : Acutus Medical, Inc., Q2 2023 Earnings Call, Aug 07, 2023	07/08/23
Earnings Flash (AFIB) ACUTUS MEDICAL Reports Q2 Revenue $5.3M, vs. Street Est of $4.5M	07/08/23	MT
Acutus Medical, Inc. Provides Revenue Guidance for the Year 2023	07/08/23	CI
Acutus Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	07/08/23	CI
Acutus Medical, Inc. Announces Executive Changes	05/07/23	CI
Acutus Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	11/05/23	CI
Transcript : Acutus Medical, Inc., Q1 2023 Earnings Call, May 11, 2023	11/05/23
Earnings Flash (AFIB) ACUTUS MEDICAL Posts Q1 Revenue $4.2M	11/05/23	MT
Acutus Medical, Inc. Provides Revenue Guidance for the Year 2023	11/05/23	CI
Transcript : Acutus Medical, Inc. - Special Call	21/04/23
Acutus Medical, Inc. Provides Revenue Guidance for the First Quarter 2023	20/04/23	CI
Transcript : Acutus Medical, Inc., Q4 2022 Earnings Call, Mar 16, 2023	16/03/23

Chart Acutus Medical, Inc.

Duration

Period

More charts

Company Profile

Acutus Medical, Inc. is focused on the production of left-heart access products under its distribution agreement with Medtronic, Inc. (Medtronic). The Company is solely focused on supporting the manufacturing and distribution of products to Medtronic. It manufactures transseptal crossing devices and associated accessories, such as integrated transseptal dilators and needles, fixed-curve or steerable introducers, and steerable sheaths (Products). These Products are used to access the left side, or left atrium, of the cardiac anatomy and are used in a range of medical applications, including in electrophysiology and structural heart procedures. The technology supports physicians during a critical component of an ablation or structural heart procedure. The transseptal crossing devices that it manufactures for Medtronic include versions that are length-, diameter- and tip-matched and designed to lock into the hub of sheaths used in many left-heart procedures.

Sector

Medical Equipment, Supplies & Distribution

Calendar

13/06/2024 - Annual General Meeting

More about the company

	1st Jan change	Capi.
ACUTUS MEDICAL, INC.	-70.78%	1.34M
STRYKER CORPORATION	+11.76%	127B
SMITH & NEPHEW PLC	-5.10%	11.32B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+4.02%	9.04B
GLAUKOS CORPORATION	+38.12%	5.56B
INSPIRE MEDICAL SYSTEMS, INC.	-23.70%	4.72B
AXONICS, INC.	+8.55%	3.45B
ENOVIS CORPORATION	-6.44%	2.86B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-5.85%	2.07B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-11.84%	2.04B

Medical Devices & Implants